Skip to main content
. 2021 Jun 7;91(3):480–488. doi: 10.1097/TA.0000000000003305

TABLE 2.

Interventions

All (n = 145), n (%) Pregroup (n = 78), n (%) Postgroup (n = 67), n (%) p
Vast irreversible ischemia, palliative care 16 (11) 11 (14) 5 (7) 0.203
Revascularization done 109 (75) 53 (68) 56 (84) 0.030
EVT 69 (48) 26 (33) 43 (64) <0.001
Open embolectomy 29 (20) 19 (24) 10 (15) 0.157
Bypass surgery 24 (17) 14 (18) 10 (15) 0.625
No revascularization, active treatment 20 (14) 14 (18) 6 (9) 0.142
EVT without laparotomy 20 (14) 7 (9) 13 (19) 0.070
Laparotomy 125 (86) 71 (91) 54 (81) 0.069
Bowel resection 81 (56) 46 (59) 35 (52) 0.415
Length of bowel resection (n = 81), cm 70 (32.5–129.5) 62.5 (28.75–112.5) 73 (40–200) 0.106*
Open abdomen, laparotomy patients (n = 125) 43 (30) 20 (28) 23 (43) 0.093
Primary intervention circumstance
 – Hybrid OR 47 (32) 8 (10) 39 (58) <0.001
 – Conventional OR 72 (50) 57 (73) 15 (22) <0.001
 – Angio suite 26 (18) 13 (17) 13 (19) 0.668
EVT Access All (n = 69), n (%) Pregroup (n = 26), n (%) Postgroup (n = 43), n (%) p
Femoral artery 46 (67) 21 (81) 25 (58) 0.028
Brachial artery 9 (13) 2 (8) 7 (16) 0.466**
SMA (ROMS) 10 (14) 2 (8) 8 (19) 0.299**
Combination 4 (6) 1 (4) 3 (7) 1.000**
EVT Procedures† All (n = 73), n (%) Pregroup (n = 29), n (%) Postgroup (n = 44), n (%) p
Stent (+/− thrombectomy/embolectomy) 53 (73) 17 (59) 36 (82) 0.030
Embolectomy 15 (21) 9 (31) 6 (14) 0.084
Balloon dilatation 2 (3) 2 (7) 0 (0) 0.155**
Unsuccessful attempt 3 (4) 1 (3) 2 (5) 1.000**
Target, SMA 64 (88) 25 (86) 39 (89) 0.734
Target, celiac trunk 9 (12) 4 (14) 5 (11) 0.734**

Continuous variables are presented as median (interquartile range). Boldface indicates statistical significance.

*Mann-Whitney U test.

**Fischer’s exact test (others, χ2).

†Patient may have multiple procedures.

ROMS, retrograde open mesenteric stenting; SMA, superior mesenteric artery.